Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Why would they get rid of our genius chief scientist when
View:
Post by edrose on Mar 17, 2021 3:57pm

Why would they get rid of our genius chief scientist when

Your a biotech company developing molecules 
and can't understand why they cancelled both ivig and ryplasim when there close to approval at phase 3  with good results and no side effects 


CAN SOMEONE EXPLAIN TO RETAIL INVESTORS THEIR RATIONAL

Comment by stockman6767 on Mar 17, 2021 5:55pm
Edrose, you posted "they cancelled both ivig and ryplasim when there close to approval at phase 3  with good results and no side effects " When did they "cancel" or drop Ryplazim? I am aware that they spoke of selling the Ryplazim franchise but never of cancelling that project - at least not that I am aware of. Can you please expalin what you mean, and how you heard of ...more  
Comment by PLITheOne on Mar 17, 2021 7:04pm
 It has therefore determined that its plasma-derived therapeutics business is no longer aligned with this new corporate business strategy. NR
Comment by 4Justice on Mar 17, 2021 8:32pm
 Wake up! Who as the skill and technology to produce Ryplazim ? Liminal wants to sell everything and NOT produce. Stop dreaming, there will be no deal and no aprouval because there are no more people able to operate the plant and produce someting with the breakthrought PPPS technology.
Liminal BioSciences Inc.